-
Haemonetics Reports Q3 EPS of $.89 vs. $.82
Monday, January 31, 2011 - 9:07am | 69Haemonetics Corporation (NYSE: HAE) today reported GAAP net revenues of $176.8 million, up 7%, net income of $19.7 million, up 8%, and earnings per share of $0.77, up 10%. Excluding transformation costs in fiscal 11, adjusted third quarter net income was $ 22.6 million, up 21%, and adjusted...
-
Vaccines Pull Down NVS Q4 Earnings - Analyst Blog
Friday, January 28, 2011 - 11:31am | 1010Novartis (NVS) reported earnings per share of $1.14 for the fourth quarter of 2010, much below the Zacks Consensus Estimate of $1.21 and the year-earlier earnings of $1.26 per share. The substantial drop from the base period was due to robust profits booked in 2009 from windfall sales of H1N1 flu...
-
Vaccines Pull Down NVS Q4 Earnings - Analyst Blog
Friday, January 28, 2011 - 11:15am | 1010Novartis (NVS) reported earnings per share of $1.14 for the fourth quarter of 2010, much below the Zacks Consensus Estimate of $1.21 and the year-earlier earnings of $1.26 per share. The substantial drop from the base period was due to robust profits booked in 2009 from windfall sales of H1N1 flu...
-
Novartis to Buy Genoptix - Analyst Blog
Friday, January 28, 2011 - 9:40am | 524Novartis (NVS) recently announced that it has entered into a definitive agreement to acquire California based diagnostic laboratory, Genoptix Inc. (GXDX), for a cash consideration of $470 million. Genoptix is a specialist in providing personalized diagnostic services to community-based...
-
Novartis to Buy Genoptix - Analyst Blog
Friday, January 28, 2011 - 9:15am | 524Novartis (NVS) recently announced that it has entered into a definitive agreement to acquire California based diagnostic laboratory, Genoptix Inc. (GXDX), for a cash consideration of $470 million. Genoptix is a specialist in providing personalized diagnostic services to community-based...
-
Align's Earnings Miss Estimates - Analyst Blog
Thursday, January 27, 2011 - 5:01pm | 749Align Technology (ALGN) reported fourth quarter adjusted EPS of 14 cents, missing both the Zacks Consensus Estimate of 17 cents and the year-ago quarter's 16 cents. For fiscal 2010, adjusted EPS came in at 80 cents, missing the Zacks Consensus Estimate by 2 cents, but higher than 41 cents in 2009...
-
Align's Earnings Miss Estimates - Analyst Blog
Thursday, January 27, 2011 - 4:20pm | 749Align Technology (ALGN) reported fourth quarter adjusted EPS of 14 cents, missing both the Zacks Consensus Estimate of 17 cents and the year-ago quarter's 16 cents. For fiscal 2010, adjusted EPS came in at 80 cents, missing the Zacks Consensus Estimate by 2 cents, but higher than 41 cents in 2009...
-
Alcon's Winning Streak Continues - Analyst Blog
Thursday, January 27, 2011 - 1:01pm | 666Alcon Inc. (ACL) reported fourth quarter 2010 earnings of $1.74 per share, beating the Zacks Consensus Estimate of $1.70 and 8.1% ahead of the year-ago figure. The fiscal year also saw the company beating the Zacks Consensus Estimate by 4 cents. Earnings in fiscal year 2010 came in at $7.71 per...
-
Alcon's Winning Streak Continues - Analyst Blog
Thursday, January 27, 2011 - 12:30pm | 666Alcon Inc. (ACL) reported fourth quarter 2010 earnings of $1.74 per share, beating the Zacks Consensus Estimate of $1.70 and 8.1% ahead of the year-ago figure. The fiscal year also saw the company beating the Zacks Consensus Estimate by 4 cents. Earnings in fiscal year 2010 came in at $7.71 per...
-
Options Brief: Align Technology (ALGN)
Thursday, January 27, 2011 - 11:56am | 92Shares of Align Technology (NASDAQ: ALGN) are higher on the session by 1.90%, trading at $20.90. Overall put volume is now running at 8.82x the daily average, with 8% of all puts traded being purchases on the offer. 2,231 contracts have traded on the session so far. Align Technology, Inc. designs...
-
Align Technology Announces Fourth Quarter and Fiscal 2010 Results
Wednesday, January 26, 2011 - 5:14pm | 124Align Technology, Inc. (NASDAQ: ALGN) today reported financial results for the fourth quarter and fiscal year ended December 31, 2010. Total net revenues for the fourth quarter of fiscal 2010 (Q4 10) were $92.9 million compared to $95.9 million reported in the third quarter of 2010 (Q3 10) and...
-
Rochester Medical Reports Q1 EPS of $(0.01)
Tuesday, January 25, 2011 - 5:02pm | 73Rochester Medical Corporation (Nasdaq: ROCM) today announced operating results for its first quarter ended December 31, 2010. The Company reported sales of $10,946,000 for the current quarter compared to $10,232,000 for the first quarter of last year. The Company also reported net loss of ($169,...
-
Bearish MACD for STAA - Tale of the Tape
Tuesday, January 25, 2011 - 1:01pm | 116STAAR Surgical Company's (STAA) MACD indicator has entered into bearish territory with a reading of -0.0690. The Zacks #5 Rank (“Strong Sell”) stock decreased slightly to $5.41 in morning trade. The Zacks Consensus Estimate for the year ended December 2010 has worsened by 4 cents over the past...
-
Bearish MACD for West Pharma - Tale of the Tape
Tuesday, January 25, 2011 - 12:31pm | 115West Pharmaceutical Services Inc.'s (WST) MACD indicator has entered into bearish territory with a reading of -0.2556. The Zacks #4 Rank (“Sell”) stock decreased slightly to $39.37 in morning trade. The Zacks Consensus Estimate for the year ended December 2010 has decreased by a penny over the past...
-
Bearish MACD for STAA - Tale of the Tape
Tuesday, January 25, 2011 - 12:25pm | 116STAAR Surgical Company's (STAA) MACD indicator has entered into bearish territory with a reading of -0.0690. The Zacks #5 Rank (“Strong Sell”) stock decreased slightly to $5.41 in morning trade. The Zacks Consensus Estimate for the year ended December 2010 has worsened by 4 cents over the past...